<?xml version="1.0" encoding="UTF-8" standalone="yes" ?>
<!-- SwishCommand noindex -->
<rss version="2.0">
<channel>
  <title>ComplianceHome: FDA Events</title>
  <link>http://www.compliancehome.com/</link>
  <description>ComplianceHome is one of the Web's largest library of resources for compliance management of HIPAA, SOX, FISMA, GLBA, FDA, COOP &amp; COG, FFIEC, Basel II, OSHA and ISO 27002/17799. Visit our directories which are the best source on White papers, related news articles, resources on the web, training, webinars, conferences, rules &amp; regulation overview, ask the expert, job and search on vendors, solutions &amp; products.</description>
<image>
  <url>http://www.compliancehome.com/images/rsslogo.gif</url>
  <title>ComplianceHome</title>
  <link>http://www.compliancehome.com/</link>
</image>
  <language>en-us</language>
  <item>
    <title>Writing and Enforcing Effective SOPs: Avoid Regulatory Action and Improve Efficiency</title>
    <pubDate>Mon, 05 May 2008 00:00:00 CST</pubDate>
    <link>http://www.compliancehome.com/events/FDA/Webinars/details10982.html</link>
    <description>2008-05-21  None &lt;br&gt; Sign up to learn:&lt;br /&gt;&lt;br /&gt;    * How to develop an effective SOP, including five tips to help you write clear, effective instructions&lt;br /&gt;    * How to set up your SOP writing process so you know who's responsible for what and how often to review and update your procedures&lt;br /&gt;    * What level of detail is appropriate when drafting an SOP&lt;br /&gt;    * The best ways to include those who are involved in SOP development, as well as the right and wrong ways to gather procedure information&lt;br /&gt;    * How to conduct effective SOP training and motivate your staff&lt;br /&gt;    * Steps for monitoring and auditing SOP compliance&lt;br /&gt;    * Exactly what documents may be considered SOPs&lt;br /&gt;    * How to avoid common SOP problems, such as including too much or too little detail, or writing an SOP that's outside your process or inconsistent with your technology&lt;br /&gt;</description>
    <guid isPermaLink="false">http://www.compliancehome.com/events/FDA/Webinars/details10982.html</guid>
  </item>
  <item>
    <title>Combating Counterfeit and Diverted Drugs: A Lipitor Case Study and Top 10 Strategies for Protecting Your Products</title>
    <pubDate>Thu, 01 May 2008 00:00:00 CST</pubDate>
    <link>http://www.compliancehome.com/events/FDA/Webinars/details10971.html</link>
    <description>2008-05-14  None &lt;br&gt; Sign up your entire team to listen in and discover:&lt;br /&gt;&lt;br /&gt;    * Lessons learned from the Lipitor case and five best practices to identify counterfeit schemes&lt;br /&gt;    * The extent and depth of the drug-counterfeiting problem and which drug classes are next&lt;br /&gt;    * The industry's role in fighting counterfeiting&lt;br /&gt;    * What effect counterfeiting has on your relationship with wholesalers and pharmacies&lt;br /&gt;    * Top 10 ways fake drugs wind up in legitimate supply chains&lt;br /&gt;    * The next breed of counterfeiters and what they have in mind&lt;br /&gt;    * New ideas for getting inside the minds of counterfeiters&lt;br /&gt;    * What the government is doing  and not doing  about the problem&lt;br /&gt;    * Three not-so-obvious reasons for lack of news coverage of counterfeiters, even when they get caught&lt;br /&gt;    * The latest initiatives and resources the industry is bringing to bear to fight counterfeiters&lt;br /&gt;</description>
    <guid isPermaLink="false">http://www.compliancehome.com/events/FDA/Webinars/details10971.html</guid>
  </item>
</channel>
</rss>
